The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and Therapeutics
Open accessAbstract
Nicotine sustains tobacco addiction, a major cause of disability and premature death. Nicotine binds to nicotinic cholinergic receptors, facilitating neurotransmitter release and thereby mediating the complex actions of nicotine in tobacco users. Dopamine, glutamate, and gamma aminobutyric acid release are particularly important in the development of nicotine dependence, and corticotropin-releasing factor appears to contribute to nicotine withdrawal. Nicotine dependence is highly heritable. Genetic studies indicate roles for nicotinic receptor subtypes, as well as genes involved in neuroplasticity and learning, in development of dependence. Nicotine is primarily metabolized by CYP 2A6, and variability in rate of metabolism contributes to vulnerability to tobacco dependence, response to smoking cessation treatment, and lung cancer risk. Tobacco addiction is much more common in persons with mental illness and substance abuse disorders, representing a high proportion of current smokers. Pharmacotherapeutic approaches to tobacco addiction include nicotine replacement, bupropion, and varenicline, the latter a selective nicotine receptor partial agonist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, clinical, and preclinical research has demonstrated that gestational nicotine exposure causes alterations to development in regions such as the PFC, VTA, NA, and caudate and may contribute towards the development of ADHD, schizophrenia, anxiety, obesity, and future adolescent substance abuse [17].”
From Prenatal nicotine exposure during pregnancy results in adverse neurodevelopmental alterations and neurobehavioral deficits (2023) · cites this paper as [17]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The pharmacokinetic profile of nicotine during cigarette smoking is a rapid rise and fall in plasma nicotine concentrations [5].”
From A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette (2022) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
The Health Consequences of Smoking: A Report of the Surgeon General
Office on Smoking (2004) · Cited by 2,414
Signs and Symptoms of Tobacco Withdrawal
Hughes, J. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800030107013 · Cited by 1,669
Metabolism and Disposition Kinetics of Nicotine
Hukkanen, J., Jacob, P., & Benowitz, N. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.3 · Cited by 1,583
Self-citationA Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 Update
(2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.04.009 · Cited by 1,410
Synaptic plasticity and addiction
Kauer, J. A., & Malenka, R. C. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2234 · Cited by 1,397
Is there a common molecular pathway for addiction?
Nestler, E. J. (2005) · Nature Neuroscience · doi:10.1038/nn1578 · Cited by 1,388
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Research works printed but not linked: 4
- Cent. Dis. Control Prev, 2002, MMWR, 51, 637
- Colton CW, 2006, Prev. Chronic Dis., 3, A42
- Slemmer JE, 2000, J. Pharmacol. Exp. Ther., 295, 321
- Cahill K, 2007, Cochrane Database Syst. Rev., 2007, CD005353
Cited by
Sorted by citations
Items 601–700 of 978
Braunscheidel, K. M., Voren, G., Fowler, C. D., Lu, Q., Kuryatov, A., Cameron, M. D., Ibáñez-Tallon, I., Lindstrom, J. M., Kamenecka, T. M., & Kenny, P. J. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1459098 · Cited by 3
Role of Nanomedicine in Transforming Pharmacotherapy for Substance Use Disorder ( SUD )
Patne, A. Y., Mohapatra, S., & Mohapatra, S. S. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70008 · Cited by 3
Vann, R. E., Tobey, K. M., Lobe, S., Kipps, B. R., Kwilasz, A. J., Aceto, M. D. G., & Harris, L. S. (2010) · Drug Development Research · doi:10.1002/ddr.20431 · Cited by 3
A Mixed Method Review of Tobacco Cessation for the Cardiopulmonary Rehabilitation Clinician
Mola, A. M., Lloyd, M. M., & Villegas-Pantoja, M. Á. (2017) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000268 · Cited by 3
Medications to Treat Addictions
Herman, A. I., & Sofuoglu, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398338-1.00035-x · Cited by 3
THE ADVOCACY AND COMMUNICATION OF SMOKE-FREE AREA REGULATION IN EAST JAVA, INDONESIA
Widati, S., Martini, S., Artanti, K. D., Megatsari, H., Wiseman, N., & Harris, N. (2022) · Jurnal Administrasi Kesehatan Indonesia · doi:10.20473/jaki.v10i2.2022.232-240 · Cited by 3
CYP2A6Effects on Subjective Reactions to Initial Smoking Attempt
Cannon, D. S., Mermelstein, R. J., Medina, T. R., Pugach, O., Hedeker, D., & Weiss, R. B. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv244 · Cited by 3
Role of Cytochrome P450 Systems in Substance of Abuse Mediated HIV-1 Pathogenesis and NeuroAIDS
Kumar, S. (2012) · Journal of Drug Metabolism & Toxicology · doi:10.4172/2157-7609.1000e102 · Cited by 3
A Narrative Review of Smoking Cessation Practices in Jordan
el Hait, S. S. (2017) · Journal of pharmacology & clinical research · doi:10.19080/jpcr.2017.02.555591 · Cited by 3
Wu, I.-H., Chen, H., Bordnick, P., Essien, E. J., Johnson, M., Peters, R. J., & Abughosh, S. (2017) · Archives of Psychiatry and Mental Health · doi:10.29328/journal.apmh.1001001 · Cited by 3
Gender Moderates Chronic Nicotine Cigarette Effects on Verbal Memory in Young Adults
Kangiser, M. M., Lochner, A., Thomas, A. M., & Lisdahl, K. M. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2019.1613432 · Cited by 3
Laadraoui, J., Aboufatima, R., Ouarhach, A., Bezza, K., Gabbas, Z. E., Mehdi, A. L., Marhoume, F., Kebbou, A., & Chait, A. (2019) · Toxicological & Environmental Chemistry Reviews · doi:10.1080/02772248.2019.1628236 · Cited by 3
Study on controlling nicotine release from snus by the SIPN membranes
Zhan, X., Xiaopeng, J., & Mao, Z. (2021) · e-Polymers · doi:10.1515/epoly-2021-0048 · Cited by 3
Electronic cigarettes as a harm reduction concept for public health
Farsalinos, K. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85215-9.00036-2 · Cited by 3
Morris, E. D., Kim, S., Sullivan, J. M., Wang, S., Normandin, M. D., Constantinescu, C. C., & Cosgrove, K. (2013) · Journal of Visualized Experiments · doi:10.3791/50358-v · Cited by 3
The Effects of Drugs of Abuse on ABC Transporters
Hussein, N. A., Muskiewicz, D. E., Terrero, D., Malla, S., Hall, F. S., & Tiwari, A. K. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_184 · Cited by 3
N-Glucuronidation of Drugs and Other Xenobiotics
Kaivosaari, S. (2010) · Työväentutkimus Vuosikirja · Cited by 3
Kurko, T. (2015) · Työväentutkimus Vuosikirja · Cited by 3
Bates, C., Youdan, B., Bonita, R., Laking, G. R., Sweanor, D., & Beaglehole, R. (2022) · doi:10.32388/8wxh0j · Cited by 3
Shiffman, S. (2013) · Addiction · doi:10.1111/add.12363 · Cited by 3
Is hospitalization a missed opportunity to intervene on tobacco cessation?
Nielsen, E. M., Zhang, J., Marsden, J. E., Bays, C., Moran, W. P., Mauldin, P. D., Lenert, L. A., Toll, B. A., Schreiner, A. D., & Heincelman, M. E. (2023) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2023.11.024 · Cited by 2
Gomez, F., Ayo-Yusuf, O. A., Yershova, K., Jain, V. K., Alcheva, A., Hatsukami, D. K., Parascandola, M. J., & Stepanov, I. S. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00181 · Cited by 2
Naudé, G. P., Strickland, J. C., Berry, M. S., Dolan, S. B., Cox, D. J., & Johnson, M. W. (2024) · Journal of the Experimental Analysis of Behavior · doi:10.1002/jeab.4223 · Cited by 2
Hu, N., Xin, N., Wang, Y., Liu, D., Zhao, Y., Xu, M., Li, F., Miao, J., Ji, S., & Wang, L. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118625 · Cited by 2
Mallevays, M., Mauries, S., Maruani, J., Frija‐Masson, J., Zehani, F., Lejoyeux, M., d’Ortho, M., & Geoffroy, P. A. (2025) · Sleep Medicine · doi:10.1016/j.sleep.2025.106894 · Cited by 2
Pastina, J. T., & Stewart, L. K. (2025) · Journal of Dietary Supplements · doi:10.1080/19390211.2025.2589784 · Cited by 2
Assessment of psychological tobacco dependence among medical students: a cross-sectional study
Aslan, A., Kurt, O., & Avcu, A. B. (2025) · Turkish Journal of Tobacco Control · doi:10.64511/tjtc.2025.20 · Cited by 2
Olawale, M. E., & Lazarus, P. J. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103792 · Cited by 3
Understanding varenicline function via key receptor and ligand interactions
Aiken, S., Fiorito, D., Harper, M., Pikus, G., Underhill, J., Murray, J., Rawlinson, J., O’Donoghue, A. C., Gotti, C., Lummis, S. C. R., et al. (2025) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2025.102992 · Cited by 3
Gupta, A., Dixit, P., Bansal, A., & Lahoti, S. (2026) · Discover Public Health · doi:10.1186/s12982-025-01337-4 · Cited by 2
Staaf, M., Masser, A. E., Pramfalk, C., Pendrill, R., Moses, S., Lindholm, J., & Ljung, T. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113050 · Cited by 3
Electrochemical Sensing of Nicotine Using Poly(Safranine)/MoS 2 Nanocomposite Modified Electrode
Narayanan, N., Sharif, S. I. U., Sridharan, G., Atchudan, R., Arya, S. K., & Sundramoorthy, A. K. (2026) · Analytical Letters · doi:10.1080/00032719.2026.2682376 · Cited by 2
Recent advances in intraoral, buccal and sublingual drug delivery systems and technologies
Protopapa, C., Vlachou, M., & Peppas, N. A. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115127 · Cited by 2
Correlates of former smoking in patients with cerebrovascular disease: a cross-sectional study
Edjoc, R., Reid, R. D., Sharma, M., Balfour, L., & Procino, M. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-005753 · Cited by 2
Bourin, M., & Chagraoui, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-50530-5_23 · Cited by 2
Psychoactive plants and phytochemicals
Salem, M. A., Zayed, A., & Ezzat, S. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821556-2.00028-1 · Cited by 2
Barker, A. M., Moore, H. N., & Buffalari, D. M. (2022) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntac109 · Cited by 2
Gautam, N., Shivalingesh, K., Satyaki, V., Kumar, V., & Isha, S. (2022) · Journal of Addiction Medicine and Therapeutic Science · doi:10.17352/2455-3484.000052 · Cited by 4
Turpin, M. A. C., Rowland, K. C., Anugwom, C., Arocha, M., Carona, A., Gonzalez, B. I., Iskander, G., Snyder, S., Wilson, K., Kaye, A. D., et al. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98814-8.00027-5 · Cited by 3
Fields, L., Roberts, W., Schwing, I., McCoy, M. F., Verplaetse, T. L., Peltier, M. R., Carretta, R. F., Zakiniaeiz, Y., Rosenheck, R. A., & McKee, S. A. (2023) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2023.100162 · Cited by 3
Jin, Y., Xu, S., Luo, X., Wang, Y., Li, J., Liang, B., Li, H., Wang, X., Sun, X., & Wang, Y. Y. (2023) · Journal of Global Health · doi:10.7189/jogh.13.04037 · Cited by 2
The tobacco epidemic – pharmacological interventions for smoking cessation
Sergiel, N., Maj, P., Włodarczyk-Cybulska, K., Kania, A., Gonet, M., Miszczyk, K., Serwik-Trandasir, A., Mozer, P., Maternia, J., & Lazar, M. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.46.01.024 · Cited by 3
Arumugam, M., Sundaram, R. L., Jayajothi, V., Arul, M., Suresh, J. A., & Kesavan, S. K. (2023) · Advances in Redox Research · doi:10.1016/j.arres.2023.100089 · Cited by 4
An Updated Review of Nicotine in Gastrointestinal Diseases
Wal, P., Aziz, N., Patel, A., & Wal, A. (2023) · The Open Public Health Journal · doi:10.2174/0118749445271127231116130459 · Cited by 2
Molecular docking study of ginger (Zingiber officinale) on Immunoglobulin A for smoking cessation
Alamsyah, R. M., Satari, M. H., Pintauli, S., & Iskandar, S. (2024) · Pharmacia · doi:10.3897/pharmacia.71.e116751 · Cited by 2
郑, 郁., 孙, 梦., 白, 春., & 杨, 达. (2024) · 元宇宙医学. · doi:10.61189/379779ioemkb · Cited by 2
The rapeutic impact of alkaloids in neurological diseases: A promising key molecule
Kaur, S., Kaur, G., Rana, R., Kumar, B., Melkani, I., Kumar, S., Pandey, N. K., Singh, S., Baghel, D. S., Joshi, K., et al. (2024) · E3S Web of Conferences · doi:10.1051/e3sconf/202455601004 · Cited by 2
Newton, K. A., & Biase, L. M. D. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_19 · Cited by 3
Baek, C.-W., Park, J., Kim, D., Kim, H. J., Lee, A.-N., Shin, J., Cho, S.-K., Kim, H.-I., & Choi, Y.-H. (2024) · Korean Journal of Family Medicine · doi:10.4082/kjfm.23.0179 · Cited by 2
Truman, P., Atigari, D. V., Kidwell, M., Colussi‐Mas, J., & Ellenbroek, B. A. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06712-8 · Cited by 3
Racial and nonracial discrimination and tobacco use among high school students in California
Harris, C. D., Dutra, L. M., Donaldson, C. D., Bradfield, B. R., Russell, S. T., Baum, L. E., & Zhang, X. (2024) · Social Science & Medicine · doi:10.1016/j.socscimed.2024.117574 · Cited by 2
Schiek, H., Esch, T., & Hoetger, C. (2025) · BMC Digital Health · doi:10.1186/s44247-025-00147-7 · Cited by 4
Hammad, A. M., Syaj, H., Abusara, O. H., Khdair, S. I., Debas, R., & Hall, F. S. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115600 · Cited by 3
Smoking and the risk of prostate cancer: a review of risk and disease progression
Sundaresan, I., Palanisamy, N., & Saraswathy, R. (2025) · Genes and Environment · doi:10.1186/s41021-025-00338-8 · Cited by 2
Insight into nicotine addiction
Handa, S., Kour, H., & Khurana, C. (2017) · CHRISMED Journal of Health and Research · doi:10.4103/2348-3334.201993 · Cited by 2
Dopamine D4 receptor gene exon III VNTR variant influences smoking status in Turkish population
Uysal, M. A., Sever, Ü., Nursal, A. F., Yedikule Smoking Cessation Study Group, & Pehlıvan, S. (2019) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.23408 · Cited by 3
Ethics. A code for the laboratory.
Statland, B. E. (1995) · PubMed · Cited by 2
Pipe, A. (2014) · BMJ Evidence-Based Medicine · doi:10.1136/eb-2014-110030 · Cited by 2
Effects of doxepin on physiology of reproduction in adult male rats
Shariati, M., Mokhtari, M., Amiri, F., & Kazemi, M. R. (2010) · Cited by 2
Klempfner, R., Goldenberg, I., Fisman, E. Z., Amit, U., Haitovich, A., Matetzky, S., Medvedofsky, D. A., Shemesh, J., & Tenenbaum, A. (2013) · Cardiology Journal · doi:10.5603/cj.a2013.0127 · Cited by 2
A Novel Engineering Approach to Modeling and Optimizing Smoking Cessation Interventions
Timms, K. P. (2014) · Cited by 2
Dopaminergic Neurons in the Ventral Tegmental Area and Their Dysregulation in Nicotine Addiction
Dumont, G., Maex, R., & Gutkin, B. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809825-7.00003-1 · Cited by 2
The Deep Roots of Addiction: A Comparative Perspective
Karnib, N., & van Staaden, M. J. (2020) · Brain Behavior and Evolution · doi:10.1159/000514180 · Cited by 2
Association of NRG3 and ERBB4 gene polymorphism with nicotine dependence in Turkish population
Kara, H. G., Erdal, M. E., Yılmaz, Ş. G., Şengül, C., Şengül, C. B., & Karakülah, K. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06548-x · Cited by 2
Alsaafin, A., Chenoweth, M. J., Sylvestre, M., O’Loughlin, J. L., & Tyndale, R. F. (2022) · Addiction · doi:10.1111/add.15871 · Cited by 3
The Importance of Conventional Toxicological Metrics of Aerosol Characterization
Noël, A., Campen, M. J., & McKinney, W. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac081 · Cited by 2
Grunt jej mać. Kobiece narracje z górnośląskich marginesów – prolegomena
Pospiszil, K. (2023) · Wielogłos · doi:10.4467/2084395xwi.23.026.18861 · Cited by 2
Effects of Chronic Nicotine Administration on Salivary Gland in Mice: Immunohistochemical Study
Jung, J.-W., Choi, J., & Byun, J. (2014) · Journal of Oral Medicine and Pain · doi:10.14476/jomp.2014.39.3.83 · Cited by 2
Torres, L. H., Garcia, R. C. T., Camarini, R., & Marcourakis, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805373-7.00024-4 · Cited by 2
A Review on the Receptor-ligand Molecular Interactions in the Nicotinic Receptor Signaling Systems
Liu, W., & Su, K. (2018) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2018.51.66 · Cited by 2
Weidner, K., Behnes, M., Rusnak, J., Taton, G., Schupp, T., Reiser, L., Bollow, A., Reichelt, T., Ellguth, D., Engelke, N., et al. (2018) · Cardiology Journal · doi:10.5603/cj.a2018.0158 · Cited by 2
Levin, B., Wilks, I., Tan, S., Behnood‐Rod, A., & Bruijnzeel, A. W. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9554-7_14 · Cited by 2
Delirium and Nicotine Withdrawal
Kataria, D. K., Ankit, G., Tiwari, S., & Kukreti, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813035-3.00028-9 · Cited by 2
Photochromic Modulation of Cys-loop Ligand-gated Ion Channels
Bregestovski, P. D., & Ponomareva, D. (2021) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093021020162 · Cited by 2
Allen, A. M. (2012) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 2
Smoking Prevention and Cessation
Prokhorov, A. V., & Hudmon, K. S. (2014) · Lung Cancer · doi:10.1002/9781118468791.ch1 · Cited by 2
Current Pharmacotherapies for Smoking Cessation and Promising Emerging Drugs
Dodd, S., Harper, J., & Berk, M. (2023) · Current Clinical Pharmacology · doi:10.2174/0127724328274939231121114142 · Cited by 1
Obia, O., Nda-ue, L., Ojeka, S. O., Ogba, A., & Nwokocha, F. N. (2024) · East African Scholars Journal of Medical Sciences · doi:10.36349/easms.2024.v07i04.005 · Cited by 1
Singh, S. K., Yadav, S., Kumar, A., Singh, H., Rahman, H., Niranjan, M. M., Mittel, M. J., & Wadhawan, M. (2024) · Journal of Dental Anesthesia and Pain Medicine · doi:10.17245/jdapm.2024.24.5.351 · Cited by 1
Faillace, M. P., Rocco, L., Ortiz, J. J., & Bernabeu, R. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111242 · Cited by 1
Dhillon, A. K., Jhilta, A., Ladhi, R., Bagdwal, H., Singh, A., Verma, R. K., & Singh, M. (2025) · Nanoscale · doi:10.1039/d5nr00785b · Cited by 1
Luo, D., Zheng, Y., Yang, W., Meng, T., Ren, Y., & Wang, J. (2025) · Heart and Mind · doi:10.4103/hm.hm-d-24-00152 · Cited by 1
Strang, S., Köcher, T., van der Sluis, L., Chowdhury, M. P., Grabmayer, H., Douka, K., & Binder, M. (2025) · Journal of Archaeological Science · doi:10.1016/j.jas.2025.106301 · Cited by 1
Buchwald, J., Lehtimäki, T. J., Raitakari, O. T., Salomaa, V. V., Kaprio, J. A., & Pirinen, M. (2025) · European Journal of Epidemiology · doi:10.1007/s10654-025-01270-5 · Cited by 1
A blind spot in fMRI research: Overlooked tobacco smoking-related confounds
Koster, M., van der Pluijm, M., de Haan, L., van Wingen, G. A., & Vermeulen, J. M. (2025) · NeuroImage · doi:10.1016/j.neuroimage.2025.121382 · Cited by 1
Borowy, D., Boroń, A., Chmielowiec, J., Chmielowiec, K., Lachowicz, M., Masiak, J., Grzywacz, A., & Suchanecka, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157109 · Cited by 1
Motivation for Smoking Cessation in Patients With Oral Squamous Cell Carcinoma—A One‐Time Survey
Gruber, L. J., Bühler, M. M., Spillner, A., Andreas, S., Kauffmann, P., Schliephake, H., & Wolfer, S. (2025) · Clinical and Experimental Dental Research · doi:10.1002/cre2.70154 · Cited by 1
Vanderschelden, R. K., Kundu, R., Morrow, D., Patel, S., & Tamama, K. (2025) · Metabolites · doi:10.3390/metabo15090563 · Cited by 1
Nicotine/Tobacco and Otoneurological Symptoms/Conditions
Cherchi, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-94841-1_166 · Cited by 1
Yang, M., Hu, Z., Huang, Y., Zhang, G., Kang, F., & Chen, D. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07507-7 · Cited by 1
Nicotine-Induced VEGF Levels in NSCLC Cells Are Modulated by PKA, Hyaluronan, and p53
Wozniak, C., Cobos, A., Sabri, A., Goel, S., Lopo, B., Sarofim, S., Chutipassakul, C., Guthrie, J. W., Heyl, D., & Evans, H. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211103 · Cited by 1
Biphasic effect of nicotine on glutamatergic activity in male mouse brain
Biyani, P. P., Sarawagi, A., & Patel, A. B. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70242 · Cited by 1
Khidkikar, S. R., Malode, D., Taksande, B. G., Kale, M. B., Taksande, J., Qutub, M., Tatode, A., & Umekar, M. (2025) · Neuropeptides · doi:10.1016/j.npep.2025.102584 · Cited by 2
Anatabine: a substitute for the medicinal activity of nicotine
Guo, X., Li, Y., Liu, C., Fu, Y., & Gao, N. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178537 · Cited by 1
Shchetinina, A., Liu, X., Slopen, N. B., Chambers, C., Wolvius, E. B., Kayser, M., Roshchupkin, G. V., & Tiemeier, H. W. (2026) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174425100391 · Cited by 1
Rediscovering cytisine: Why the WHO’s decision matters for global public health
Polosa, R., & Cohen, G. A. (2026) · iScience · doi:10.1016/j.isci.2026.114874 · Cited by 1
Sekaran, S., Lakshmanan, L., & Vijayashree-Priyadarshini, J. (2026) · World Journal of Dentistry · doi:10.5005/jp-journals-10015-2754 · Cited by 1
Miyazaki, Y., Monma‐Otaki, J., Kanno, S., Ito, T., Iwai, K., Matsui, R., & Hattori, T. (2026) · Toxicology Reports · doi:10.1016/j.toxrep.2026.102231 · Cited by 1
Yu, Y. G., Kamaruzaman, P. D. I., Ganaprakasam, S. W., Bakar, N. A. A., Amin, E. S. R., & Yusof, M. J. M. (2026) · Molecules · doi:10.3390/molecules31050791 · Cited by 1
Adam, G. K., Alharbi, H. Y., Alwabili, A., & Adam, I. (2026) · BMC Public Health · doi:10.1186/s12889-026-27126-5 · Cited by 1
Metadata
- Authors
- Benowitz, N. L.
- Affiliations
- San Francisco General Hospital (US)
- Corresponding author
- Benowitz, Neal L.
- ORCID
- Benowitz, Neal L.
- Venue
- Annual Review of Pharmacology and Toxicology
- Publisher
- Annual Reviews
- Published
- 2009-02-01
- Volume
- 49
- Issue
- 1
- Pages
- 57-71
- ISSN
- 0362-1642 (ISSN-L)
- 1545-4304
- PMC
- PMC2946180
- OpenAlex
- W2137599927
- Cited by
- 979
- References
- 90
- Citations by year
- 2026: 75 · 2025: 89 · 2024: 91 · 2023: 89 · 2022: 72 · 2021: 70 · 2020: 60 · 2019: 56 · 2018: 42 · 2017: 55 · 2016: 37 · 2015: 42 · 2014: 43 · 2013: 39 · 2012: 35
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Annual Review of Pharmacology and Toxicology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Public Health Service
- National Institute on Drug Abuse (DA20830, DA02277, R01DA002277, U01DA020830, R37DA002277)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- nicotine, tobacco dependence, nicotine dependence, nicotinic acetylcholine receptors, nicotine withdrawal, dopamine release, glutamate release, GABA release, corticotropin-releasing factor, genetic susceptibility, CYP2A6, nicotine metabolism, lung cancer risk, smoking cessation, mental illness, substance abuse, nicotine replacement therapy, bupropion, varenicline, partial agonists
- MeSH terms
- Varenicline, Animals, Benzazepines, Nonprescription Drugs, Ganglionic Stimulants, Humans, Nicotine, Quinoxalines, Smoking, Tobacco Use Disorder, Bupropion, Behavior, Addictive, Nicotinic Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review